Medtronic receives FDA clearance for expanded indication of LINQ II insertable cardiac monitor for use in pediatric patients ages 2 and older Medical Device Investing
Merck to Initiate New Phase 3 Clinical Program with Lower Dose of Daily Oral Islatravir in Combination with Doravirine for Treatment of People with HIV-1 Infection Life Science Investing
Johnson & Johnson Opens State-of-the-Art Science and Technology Campus in San Francisco Bay Area Pharmaceutical Investing
COMPASS Pathways to participate in upcoming Jefferies Innovation in Mental Health Summit Psychedelics Investing
Aurinia Announces European Commission Approval of LUPKYNIS® for the Treatment of Lupus Nephritis Pharmaceutical Investing
Pfizer Announces Positive Top-Line Results from Phase 3 Study in 20-Valent Pneumococcal Conjugate Vaccine in Infants in the European Union Life Science Investing
AbbVie Secures Positive CHMP Opinion for Risankizumab for the Treatment of Adults with Moderate to Severe Crohn's Disease Pharmaceutical Investing
TCT 2022: SYMPLICITY HTN-3 trial data show sustained long-term blood pressure reductions with Medtronic renal denervation procedure Medical Device Investing
Marvel Biosciences Signs Letter of Intent with Novatech for Phase 1 Trial of MB-204 and Provides Corporate Update
